News from the debiopharm group A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 04, 2008, 00:00 ET

Clinical Update - Debio 9902 SR in Alzheimer's Disease

LAUSANNE, Switzerland, March 4 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist...

Feb 27, 2008, 00:00 ET

Debiopharm and EPFL Establish an Oncology Chair

LAUSANNE, Switzerland, February 27 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist...

Oct 31, 2007, 01:00 ET

Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories

PARIS and LAUSANNE, Switzerland, Oct. 31 /PRNewswire/ -- Ipsen (Euronext: FR0010259150; IPN) and Debiopharm Group (Debiopharm), a global...

Oct 31, 2007, 01:00 ET

Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology

LAUSANNNE, Switzerland and CHIBA, Japan, October 31 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical...

Oct 08, 2007, 01:00 ET

Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award

LAUSANNE, Switzerland, October 8 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in...

Sep 11, 2007, 01:00 ET

Debiopharm Receives cGMP Certification for Quality Control of its Drug Products

LAUSANNE, Switzerland, September 11 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist...

Aug 30, 2007, 01:00 ET

The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience

LAUSANNE, Switzerland, August 30 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in...

Jun 11, 2007, 01:00 ET

Clinical Update - Debio 9902 (ZT-1) for Alzheimer's Disease

LAUSANNE, Switzerland, June 11 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in...

Apr 19, 2007, 01:00 ET

Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment of HCV

LAUSANNE, Switzerland, April 19 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in...

Mar 12, 2007, 01:00 ET

Preclinical Update - Debio-0512 Therapeutic Vaccine for the Treatment of Chronic and Acute Inflammatory Conditions

LAUSANNE, Switzerland, March 12 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...

Nov 20, 2006, 00:00 ET

2006 Mauvernay Research Excellence Award

LAUSANNE, Switzerland, November 20 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...

Oct 31, 2006, 00:00 ET

Debiopharm Presents New Data Confirming Anti-HCV Activity of Cyclophilin Inhibitor Debio-025

LAUSANNE, Switzerland, October 31 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...

Oct 23, 2006, 01:00 ET

Debiopharm Signs International License Agreements for Sanvar(R)

LAUSANNE, Switzerland, October 23 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...

Oct 16, 2006, 01:00 ET

Debiopharm and Cambridge Antibody Technology Enter Into an Exclusive Agreement to Develop and Market SC-1 for Gastric Carcinomas

LAUSANNE, Switzerland, and CAMBRIDGE, England, October 16 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent...

Oct 11, 2006, 01:00 ET

Debiopharm and EPFL Honour Dr Eduard Batlle With the 'Debiopharm Life Sciences Award'

LAUSANNE, Switzerland, October 11 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...

Sep 21, 2006, 01:00 ET

Debiopharm Granted European Orphan Drug Status for Debio-0513 (PTR-262) for Myasthenia Gravis

LAUSANNE, Switzerland, September 21 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development...

Jul 24, 2006, 01:00 ET

Debiopharm Applies for First European Marketing Authorisation for Sanvar(R) in France

LAUSANNE, Switzerland, July 24 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...

Jun 27, 2006, 01:00 ET

Debiopharm and Aurigene Enter into Agreement to Identify and Develop Selective Compounds for Immuno-Oncology Targets

LAUSANNE, Switzerland, and BANGALORE, India, June 27 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical...

Jun 20, 2006, 01:00 ET

Moapar(R) 3 Months Approved for the Lowering of Testosterone to Castrate Serum Levels for Control of Sexual Drive in Adult Men

LAUSANNE, Switzerland, June 20 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...

Jun 14, 2006, 01:00 ET

The Debiopharm Group and Sigma-Tau Sign R&D and Commercial Agreement for Istaroxime in Acute Heart Failure Syndromes

LAUSANNE, Switzerland, June 14 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...